Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain

J Neurosci. 2005 Feb 16;25(7):1718-29. doi: 10.1523/JNEUROSCI.4835-04.2005.

Abstract

In the pilocarpine model of temporal lobe epilepsy, mossy fibers coexpress the inhibitory transmitter neuropeptide Y (NPY) with glutamate. The effects of endogenous and applied NPY on recurrent mossy fiber synaptic transmission were investigated with the use of whole-cell voltage-clamp and field recordings in rat hippocampal slices. Applied NPY reversibly inhibited synaptic transmission at recurrent mossy fiber synapses on dentate granule cells but not at perforant path or associational-commissural synapses. It also reduced the frequency of miniature EPSCs (mEPSCs) in granule cells from epileptic, but not control, rats and depressed granule cell epileptiform activity dependent on the recurrent mossy fiber pathway. These actions of NPY were mediated by activation of presynaptic Y2 receptors. The Y2 receptor antagonist (S)-N2-[[1-[2-[4-[(R,S)-5,11-dihydro-6(6H)-oxodibenz[b,e]azepin-11-yl]-1-piperazinyl]-2-oxoethyl]cyclopentyl]acetyl]-N-[2-[1,2-dihydro-3,5(4H)-dioxo-1,2-diphenyl-3H-1,2,4-triazol-4-yl]ethyl]argininamide (BIIE0246) not only blocked the effects of NPY but also enhanced recurrent mossy fiber synaptic transmission, the frequency of mEPSCs, and the magnitude of mossy fiber-evoked granule cell epileptiform activity when applied by itself. Several observations supported the selectivity of BIIE0246. These results suggest that even the spontaneous release of NPY (or an active metabolite) from recurrent mossy fibers is sufficient to depress glutamate release from this pathway. Tonic release of NPY accounts at least partially for the low probability of glutamate release from recurrent mossy fiber terminals, impedes the ability of these fibers to synchronize granule cell discharge, and may protect the hippocampus from seizures that involve the entorhinal cortex. This pathway may synchronize granule cell discharge more effectively in human brain than in rat because of its lower expression of NPY.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 2-Amino-5-phosphonovalerate / pharmacology
  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Benzazepines / pharmacology
  • Bicuculline / pharmacology
  • Convulsants / toxicity
  • Dentate Gyrus / chemistry
  • Dentate Gyrus / ultrastructure
  • Excitatory Postsynaptic Potentials / drug effects
  • Hippocampus / chemistry
  • Hippocampus / physiopathology*
  • Hippocampus / ultrastructure
  • Male
  • Mossy Fibers, Hippocampal / metabolism*
  • Mossy Fibers, Hippocampal / physiopathology
  • Neuropeptide Y / metabolism*
  • Patch-Clamp Techniques
  • Perforant Pathway / drug effects
  • Pilocarpine / toxicity
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / drug effects
  • Receptors, N-Methyl-D-Aspartate / physiology
  • Receptors, Neuropeptide Y / antagonists & inhibitors
  • Receptors, Neuropeptide Y / physiology
  • Status Epilepticus / chemically induced
  • Status Epilepticus / pathology
  • Status Epilepticus / physiopathology*
  • Synaptic Transmission / physiology*
  • Tetrodotoxin / pharmacology

Substances

  • Benzazepines
  • Convulsants
  • Neuropeptide Y
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Neuropeptide Y
  • neuropeptide Y2 receptor
  • Pilocarpine
  • Tetrodotoxin
  • 2-Amino-5-phosphonovalerate
  • Arginine
  • BIIE 0246
  • Bicuculline